WRBY
Medical Instruments & Supplies · Healthcare
CEO, Board Member
2009-01-01–present
Board Member
Warby Parker Inc. (WRBY)Equibles does not estimate personal net worth.
Get an email with a short summary when Warby Parker Inc. publishes a filing, an earnings call transcript or a press release.
Get WRBY alertsNeil Blumenthal is recorded as Board Member at Warby Parker Inc. (WRBY) since January 1, 2009 and CEO at Warby Parker Inc. (WRBY). The newest filing on record that lists Neil Blumenthal as CEO and Board Member at Warby Parker Inc. (WRBY) is dated April 28, 2026. The proxy statement of Warby Parker Inc. reports total compensation of $9,000,180 for Neil Blumenthal in fiscal 2025, including a base salary of $575,000. Disclosed compensation is on record for 6 fiscal years. Neil Blumenthal has spoken on 21 earnings calls and 1 other investor event across 1 company, most recently for Warby Parker Inc. on November 5, 2026. Warby Parker Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Warby Parker Inc. includes Dave Gilboa (CEO, CFO, Chief Accounting Officer and Board Member), Adrian Mitchell (CFO and Chief Accounting Officer), Steven Miller (CFO) and 7 others.
“Alongside the launch of Intelligent Eyewear, we remain focused on scaling our omni-channel business and delivering exceptional customer experiences. In Q3, we continue to expand our retail footprint, grow eye exams, and introduce new products and services to better serve our customers.”
“So if we think about Warby's journey, it's hard to believe we're now in our 16th year. But we started by being one of the pioneers of launching a lifestyle brand online, and we were purely e-commerce, I'd say.”
“In Q2, we generated $236 million in revenue, representing approximately 10% year-over-year growth, while continuing to make progress against our core business initiatives. particularly in eye exams, insurance, and e-commerce.”
“In the first quarter, we delivered top and bottom line results that exceeded our guidance. Revenue reached $242 million, representing 8.3% year-over-year growth, and adjusted EBITDA was $30 million, reflecting a 12.2% margin.”
“Let me begin by highlighting our three strategic priorities for 2026. Our first priority in 2026 is to further invest in scaling our industry-leading omni-channel model while delivering exceptional customer experiences.”
2009-01-01–present
Last confirmed April 28, 2026
Start not stated–present
Last confirmed April 28, 2026
WRBY
Medical Instruments & Supplies · Healthcare
CEO, Board Member
2009-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Warby Parker Inc. (WRBY) | Co-CEO and Director | $575,000 | $9,000,180 |
| 2024 | Warby Parker Inc. (WRBY) | Co-CEO and Director | $555,000 | $1,476,151 |
| 2023 | Warby Parker Inc. (WRBY) | Co-CEO and Director | $525,000 | $907,144 |
| 2022 | Warby Parker Inc. (WRBY) | Co-CEO and Director | $500,000 | $699,700 |
| 2021 | Warby Parker Inc. (WRBY) | Co-CEO and Director | $450,000 | $103,599,384 |
| 2020 | Warby Parker Inc. (WRBY) | Co-CEO and Director | $425,000 | $736,025 |